Department of Ophthalmology, University Hospital, LMU Munich, Munich, Germany.
Eye (Lond). 2023 Nov;37(16):3435-3441. doi: 10.1038/s41433-023-02529-5. Epub 2023 May 8.
PURPOSE: To evaluate the rate of misdiagnosis of aneurysmatic pachychoroid type 1 choroidal neovascularization/polypoidal choroidal vasculopathy (PAT1/PCV) among cases diagnosed as non-aneurysmatic pachychoroid neovasculopathy (PNV) and to define optical coherence tomography (OCT) features facilitating their distinction. METHODS: The database of the Department of Ophthalmology, Ludwig-Maximilians University Munich, was screened for patients diagnosed with PNV. Multimodal imaging was screened for the presence of choroidal neovascularization (CNV) and aneurysms/polyps. Imaging features facilitating the diagnosis of PAT1/PCV were analysed. RESULTS: In total, 49 eyes of 44 patients with a clinical PNV diagnosis were included, of which 42 (85.7%) had PNV and 7 (14.3%) represented misdiagnosed PAT1/PCV. SFCT was comparable (PNV: 377 ± 92 vs. PAT1/PCV: 400 ± 83 µm; p = 0.39). Whereas no difference was detected in total pigment epithelium detachment (PED) diameter (p = 0.46), maximum PED height was significantly higher in the PAT1/PCV group (199 ± 31 vs. 82 ± 46, p < 0.00001). In a receiver operating characteristic (ROC) analysis, the optimum cutoff for defining "peaking PED" was 158 µm with an area under the curve of 0.969, a sensitivity of 1.0 (95% CI: 0.59-1.0), and a specificity of 0.95 (95% CI: 0.84-0.99). Sub-retinal hyperreflective material (SHRM; p = 0.04), sub-retinal ring-like structures (SRRLS; p < 0.00001), and sub-RPE fluid (p = 0.04) were significantly more frequent in eyes with PAT1/PCV. CONCLUSION: A relevant percentage of eyes diagnosed with PNV might instead suffer from PAT1/PCV. The detection of a maximum PED height ("peaking PED") exceeding approximately 150 µm, SHRM, SRRLS, and sub-RPE fluid might greatly aid in the production of a more accurate diagnosis.
目的:评估将诊断为非动脉瘤性厚脉络膜新生血管(PNV)的病例误诊为动脉瘤性厚脉络膜 1 型脉络膜新生血管/息肉样脉络膜血管病变(PAT1/PCV)的误诊率,并确定有助于两者区分的光学相干断层扫描(OCT)特征。
方法:筛选慕尼黑路德维希-马克西米利安大学眼科数据库中诊断为 PNV 的患者。对多模态成像进行筛查,以确定是否存在脉络膜新生血管(CNV)和动脉瘤/息肉。分析有助于诊断 PAT1/PCV 的成像特征。
结果:共纳入 44 例患者的 49 只眼,临床诊断为 PNV,其中 42 只眼(85.7%)为 PNV,7 只眼(14.3%)为误诊的 PAT1/PCV。SFCT 无差异(PNV:377±92µm;PAT1/PCV:400±83µm;p=0.39)。虽然总色素上皮脱离(PED)直径无差异(p=0.46),但 PAT1/PCV 组的最大 PED 高度显著更高(199±31µm;82±46µm;p<0.00001)。在受试者工作特征(ROC)分析中,定义“高峰 PED”的最佳截断值为 158µm,曲线下面积为 0.969,灵敏度为 1.0(95%CI:0.59-1.0),特异性为 0.95(95%CI:0.84-0.99)。视网膜下高反射物质(SHRM;p=0.04)、视网膜下环状结构(SRRLS;p<0.00001)和视网膜下液(p=0.04)在 PAT1/PCV 眼中更为常见。
结论:被诊断为 PNV 的眼可能有相当比例实际上患有 PAT1/PCV。检测最大PED 高度(“高峰 PED”)超过约 150µm、SHRM、SRRLS 和视网膜下液可能极大地有助于更准确地诊断。
Ophthalmol Retina. 2020-9
Ophthalmol Retina. 2021-10
Turk J Ophthalmol. 2025-2-27
Front Med (Lausanne). 2023-10-23
Front Med (Lausanne). 2023-7-27
J Clin Med. 2021-5-17
Retina. 2021-2-1
Sci Rep. 2020-10-1
Graefes Arch Clin Exp Ophthalmol. 2021-2